Connection
Seth Heldenbrand to Antiviral Agents
This is a "connection" page, showing publications Seth Heldenbrand has written about Antiviral Agents.
|
|
Connection Strength |
|
|
|
|
|
0.622 |
|
|
|
-
Heldenbrand S, Li C, Cross RP, DePiero KA, Dick TB, Ferguson K, Kim M, Newkirk E, Park JM, Sudaria-Kerr J, Tichy EM, Ueda KR, Weng R, Wisniewski J, Gabardi S. Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+/R+) renal transplant recipients. Transpl Infect Dis. 2016 Dec; 18(6):904-912.
Score: 0.503
-
Syal G, Heldenbrand SD, Duarte-Rojo A. Seizures as a Potential Complication of Treatment With Simeprevir and Sofosbuvir. Am J Ther. 2016 Mar-Apr; 23(2):e570-1.
Score: 0.120